Skip to main content

Closed

GNLX: Genelux Corporation Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth-95.3% / yr

Operating margin-422037.5%

ROIC-132.8%

Financially safe

Stretched

Debt / equity0.11×

Interest coverage0.0×

Current ratio3.68×

Genelux Corporation

GNLXNASDAQ Global Market·USD·Closed

Genelux Corporation

GNLXNASDAQ·USD·Closed

$2.94

−3.61%

$2.94

−$0.11 (3.61%)

52W Range

10thpctl

Volume

2.19×avg

Mkt Cap

131.83MUSD

P/E

-3.3TTM

Div Yield

–ann

52W Range

10thpctl

Volume

2.19×avg

Market Cap

131.83MUSD

P/E Ratio

-3.3TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings